We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Potential Drug Target for Diabetic Retinopathy

News   Sep 20, 2019 | Original story from Elsevier

 
A Potential Drug Target for Diabetic Retinopathy

ffect of recombinant lysyl oxidase propeptide (rLOX-PP) on the development of acellular capillaries (ACs) and pericyte loss (PL) in rat retinas. A-D: Representative retinal trypsin digest images showing retinal vascular networks of a control rat (A), diabetic (DM) rat (B), rat intravitreally injected with rLOX-PP (C), and rat intravitreally injected with phosphate-buffered saline (PBS) (D). LOX-PP administration promoted the development of ACs (arrows) and PL (arrowheads) associated with diabetic retinopathy. Enlarged images correspond to boxed areas (Right panels of A, B, C, D). Scale bar = 100 μm. Credit: The American Journal of Pathology

 
 
 

RELATED ARTICLES

Imaging Tumor Stiffness To Enhance Breast and Pancreatic Cancer Treatments

News

Using a non-invasive imaging technique that measures the stiffness of tissues gives vital new information about cancer architecture and could aid the delivery of treatment to challenging tumors.

READ MORE

Novel Strategy for Synthesizing Complex Natural Products

News

Scientists have succeeded in synthesizing two complex products from a group which could be used in the development of new drugs.

READ MORE

“Sticky” Gene Could Help Valium Calm Nerves

News

Scientists have discovered that Valium and other benzodiazepines may need the assistance of a "sticky" gene, named after a mythological figure, called Shisa7, to "calm" nerves.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE